Frontiers in Pharmacology

Mini Review

Published on 06 Nov 2023

Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review

in Inflammation Pharmacology

Qiang Cao
Xinyan Wu
Qi Zhang
Junling Gong
Yuquan Chen
Yanwei You
Jun Shen
Yi Qiang
Guangzhu Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1291920

9,352 views
24 citations

Editorial

Published on 06 Nov 2023

Editorial: New drugs, approaches, and strategies to combat antimicrobial resistance

in Experimental Pharmacology and Drug Discovery

Chandra Kant Singh
Kushneet Kaur Sodhi
Mohammad S. Mubarak

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1295623

2,334 views
9 citations

Review

Published on 06 Nov 2023

Anti-atherosclerosis mechanisms associated with regulation of non-coding RNAs by active monomers of traditional Chinese medicine

in Cardiovascular and Smooth Muscle Pharmacology

Guoqing Liu
Liqiang Tan
Xiaona Zhao
Minghui Wang
Zejin Zhang
Jing Zhang
Honggang Gao
Meifang Liu
Wei Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1283494

3,418 views
6 citations

Original Research

Published on 06 Nov 2023

Cathepsin V regulates cell cycle progression and histone stability in the nucleus of breast cancer cells

in Pharmacology of Anti-Cancer Drugs

Naphannop Sereesongsaeng
James F. Burrows
Christopher J. Scott
Klaudia Brix
Roberta E. Burden

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1271435

3,772 views
12 citations

Original Research

Published on 06 Nov 2023

Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis

in Pharmacoepidemiology

Annamaria Mascolo
Concetta Rafaniello
Gabriella di Mauro
Donatella Ruggiero
Maria Rosaria Campitiello
Maria Donniacuo
Pasquale Maria Berrino
Francesco Rossi
Giuseppe Paolisso
Annalisa Capuano

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1245642

3,422 views
3 citations

Original Research

Published on 06 Nov 2023

CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients

in Pharmacogenetics and Pharmacogenomics

Teerapat Majam
Chonlaphat Sukasem
Thanyanan Reungwetwattana
Phichai Chansriwong
Chalirmporn Atasilp
Narumol Trachu
Thanaporn Thamrongjirapat
Rattanaporn Sukprasong
Jennis Meanwatthana

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1222435

3,774 views
7 citations

Original Research

Published on 06 Nov 2023

Targeting PD-1/PD-L1 inhibits rejection in a heterotopic tracheal allograft model of lung transplantation

in Experimental Pharmacology and Drug Discovery

Taisuke Kaiho
Hidemi Suzuki
Atsushi Hata
Hiroki Matsumoto
Kazuhisa Tanaka
Yuichi Sakairi
Shinichiro Motohashi
Ichiro Yoshino

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1298085

2,059 views
4 citations

Original Research

Published on 06 Nov 2023

Pharmacokinetics and absorption mechanism of tandospirone citrate

in Experimental Pharmacology and Drug Discovery

Rong Li
Yuwen Chen
Mi Jia
Xuehua Jiang
Ling Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1283103

3,362 views
3 citations

Mini Review

Published on 06 Nov 2023

Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application

in Inflammation Pharmacology

Yixin Zheng
Jianan Zhao
Mi Zhou
Kai Wei
Ping Jiang
Lingxia Xu
Cen Chang
Yu Shan
Linshuai Xu
Yiming Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1306584

4,479 views
14 citations

Original Research

Published on 03 Nov 2023

Characteristics of the gut microbiome and metabolic profile in elderly patients with sarcopenia

in Gastrointestinal and Hepatic Pharmacology

Jing Zhou
Jiang Liu
Qinqing Lin
Linhui Shi
Zhigang Zeng
Lichang Guan
Yunzi Ma
Yingtong Zeng
Shilong Zhong
Lishu Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1279448

6,668 views
18 citations

Brief Research Report

Published on 03 Nov 2023

Statutory health insurance-covered pre-exposure prophylaxis in Germany: changing trends in nationwide tenofovir disoproxil/emtricitabine prescriptions during the COVID-19 pandemic

in Pharmacoepidemiology

Henrieke Prins
Achim Dörre
Daniel Schmidt

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1241310

4,389 views
1 citation

Editorial

Published on 03 Nov 2023

Editorial: Multi-omics approaches for decoding heterogeneity in cancer immunotherapy

in Pharmacogenetics and Pharmacogenomics

Aimin Jiang
Ying Liu
Ouyang Chen
Zhigang Liu
Hongzhou Cai
Linhui Wang
Lin Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1324212

2,604 views
4 citations

Original Research

Published on 02 Nov 2023

Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR

in Pharmacology of Anti-Cancer Drugs

Yuval Bin Kanner
Qiu-Xu Teng
Assaf Ganoth
Dan Peer
Jing-Quan Wang
Zhe-Sheng Chen
Yossi Tsfadia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1290255

4,776 views
7 citations

Clinical Trial

Published on 02 Nov 2023

Effects of oral cysteine leukotriene receptor antagonist-montelukast on adenoid lymphoid tissue: a histopathological study under light microscope

in Obstetric and Pediatric Pharmacology

Zhengying Wang
Xiuling Wu
Jinghong Liu
Yu Wang
Yue Zhang
Yan Wu
Yingxue Kang
Ronghai Zhang
Jin Li
Delong Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1285647

4,106 views
3 citations

Original Research

Published on 02 Nov 2023

Antiparasitic activity of FLLL-32 against four Babesia species, B. bovis, B. bigemina, B. divergens and B. caballi, and one Theileria species, Theileria equi in vitro, and Babesia microti in mice

in Pharmacology of Infectious Diseases

Shimaa Abd El-Salam El-Sayed
El-Sayed El-Alfy
Hanadi B. Baghdadi
Mohamed Z. Sayed-Ahmed
Saad S. Alqahtani
Nawazish Alam
Sarfaraz Ahmad
Md. Sajid Ali
Ikuo Igarashi
Mohamed Abdo Rizk

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1278451

2,540 views

Original Research

Published on 02 Nov 2023

Survival nomogram for medulloblastoma and multi-center external validation cohort

in Pharmacology of Anti-Cancer Drugs

Xiang Li
Jian Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1247812

2,380 views
3 citations